The APOA1 gene provides instructions for a major part of HDL, often called “good” cholesterol, which helps carry extra cholesterol to the liver so the body can remove it. If this gene does not work well, HDL levels may be low and cholesterol can build up in blood vessels, which can increase the chance of heart disease. This gene plays an important role in keeping fat transport and blood vessel health in balance. Some rare variants in the APOA1 gene are also linked to amyloidosis, a condition where abnormal protein builds up in organs.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes contain the directions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
APOA1Gene function
What if the gene works
The APOA1 gene helps make the main protein in HDL, often called good cholesterol. This protein helps carry cholesterol from tissues to the liver so the body can reuse or clear it.
Risk
What if the gene does not work
Variants in the APOA1 gene can lower HDL cholesterol, sometimes leading to early heart and blood vessel disease. Some variants are milder, while others can also cause amyloid buildup in organs such as the kidneys, liver, or nerves.
Treatment
What does that mean for your treatment
No APOA1-specific treatment or drug choice is currently established for pathogenic or loss-of-function variants in the APOA1 gene. Care is usually guided by your cholesterol levels and overall cardiovascular risk, while the APOA1 gene is also being studied as a biomarker and as a target for HDL-raising therapies.
Conditions associated with APOA1
Gene function
What if the gene works
Your body needs a steady way to move cholesterol through the blood and back to the liver. The APOA1 gene provides instructions for the main protein in HDL, often called good cholesterol. This protein helps HDL form, pick up extra cholesterol, and carry it for processing.
The APOA1 gene makes the main protein that gives HDL particles much of their structure. This protein helps HDL form and stay stable as it moves through the bloodstream.
APOA1 helps HDL collect extra cholesterol from cells, including cells in blood vessel walls. This is part of how HDL cholesterol carries cholesterol back to the liver.
APOA1 turns on LCAT (an enzyme that changes loose cholesterol into a packed form). That step helps HDL mature and carry more cholesterol.
APOA1 helps HDL hand cholesterol to the liver. The liver can then reuse it or send some of it out in bile.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the APOA1 gene can reduce apoA-I, impair its release from cells, or change its shape so it handles fats poorly. How APOA1 gene variants affect HDL cholesterol depends on the change: some are mild, while more disruptive variants can leave little or no working protein. A few also make apoA-I form amyloid, a protein buildup in tissues. This range can influence how early low HDL or amyloid related findings appear.
How variants are linked to conditions
Variants in the APOA1 gene can cause rare inherited conditions such as APOA1 deficiency and APOA1 amyloidosis, and some people develop very low HDL cholesterol or amyloid buildup in organs. Common APOA1 gene variants and health conditions are also linked more broadly in studies, with some variants associated with differences in HDL levels and with higher or lower cardiovascular risk. These common findings influence risk, not certainty.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology, and they are widespread in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For APOA1, overall heart and blood vessel risk is shaped by more than the gene alone. Smoking, diabetes, extra body weight, low activity, and an unhealthy diet can worsen cholesterol patterns and raise risk, while regular exercise and not smoking can help support healthier levels.
Inheritance of APOA1 variants
The inheritance pattern for APOA1-related conditions can differ depending on the specific condition and variant, which is central to understanding how APOA1 variants are inherited. Some APOA1-related amyloidosis follows an autosomal dominant pattern, so a parent carrying the variant can pass it to each child with a 50% chance. In contrast, complete APOA1 deficiency is typically autosomal recessive, meaning a child usually inherits one altered APOA1 gene copy from each parent. The APOA1 gene is on chromosome 11, so one copy is inherited from each parent.
What does my APOA1 result mean for my family?
What an APOA1 result means for family members depends on the specific condition linked to that result. Some APOA1-related conditions run in families in a dominant pattern, so close relatives may also carry the same change and may want to discuss testing. Other APOA1-related findings are seen when both copies of the gene are changed, which can mean relatives are healthy carriers.
Genetic information
Genetic testing
How you find out about variants
To find variants in the APOA1 gene, clinicians use APOA1 genetic testing, usually on a blood or saliva sample. The lab reads the gene's DNA sequence and compares it with the usual reference sequence to identify changes that may help explain inherited cholesterol or triglyceride patterns.
When should I consider getting a genetic test?
Genetic testing for the APOA1 gene may be worth discussing if you or close relatives have very low HDL (“good”) cholesterol, early heart disease, or a family history of an inherited protein build-up condition called amyloidosis. It can also help explain rare kidney, liver, nerve, or heart problems that seem to run in families.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, although how much they reveal depends on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Part of the difference is that the body can absorb, break down, move, or respond to a drug in different ways based on inherited DNA changes, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed and individualized treatment decisions. More details on this topic are available in the LearnHub.
Drugs influenced by the APOA1 gene
When should I seek medical advice?
There is not yet a widely confirmed role for this gene in guiding medication choices. If you have questions about side effects, cholesterol treatment, or how well a medicine is working, talk with your doctor. APOA1 has been studied in research on how some lipid-lowering medicines may work in different people, but this has not become routine prescribing guidance.
History
Across cultures and time periods, inherited patterns were noted in families with unusual cholesterol levels long before specific genes were identified. In the 1970s and 1980s, researchers linked one of the main proteins in high density lipoprotein, often called “good cholesterol,” to the APOA1 gene. From these first observations, research expanded steadily, and rare inherited APOA1 variants helped scientists understand why some families developed early heart disease while others had unusually low or high HDL levels. Study of the APOA1 gene also shaped broader work on cholesterol transport and inherited lipid conditions. As genetic testing became more widely used, APOA1 joined the group of genes examined in people with strong family patterns of abnormal cholesterol. Its history is closely tied to the modern understanding of inherited heart risk.